Condition

Neurodegenerative Diseases

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 86 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials86
Recruiting25
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

60 shown
Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical ActivityNCT07324330 · 2025-12-04
RECRUITING
Slow-SPEED: Slowing Parkinson's Early Through Exercise DosageNCT06993142 · 2025-09-01
RECRUITING
Saliva and Extracellular Vesicles for Neurodegenerative DiseasesNCT06869135 · 2025-01-24
RECRUITING
Neurodegenerative Diseases Progression Markers (MARKERS-NDD)NCT06596746 · 2024-09-09
RECRUITING
Blood And Tears in Alzheimer's DiseaseNCT06567431 · 2024-03-18
RECRUITING
Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-NetherlandsNCT06193252 · 2024-01-15
RECRUITING
Memory Deterioration in Alzheimer DiseaseNCT07118137 · 2023-10-15
RECRUITING
Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's DementiaNCT06088121 · 2023-05-15
RECRUITING
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive AphasiaNCT05741853 · 2023-05-01
RECRUITING
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative DiseasesNCT05357612 · 2023-01-23
RECRUITING
Probiotics in Mild Alzheimer's DiseaseNCT06181513 · 2022-12-19
RECRUITING
Serotonin Release in Premotor and Motor PDNCT05516732 · 2022-07-01
RECRUITING
Molecular and Functional Imaging in Monogenic PD.NCT05518617 · 2022-07-01
RECRUITING
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide RibosideNCT05245903 · 2022-05-31
RECRUITING
Shanghai At Risk for Alzheimer's Disease: a Cohort StudyNCT05597410 · 2022-03-01
RECRUITING
Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MRNCT05205291 · 2022-02-28
RECRUITING
Longitudinal Investigation of I2BS in PDNCT05516719 · 2021-11-01
RECRUITING
Retinal Hyperspectral Imaging in Neurodegenerative DiseasesNCT07545473 · 2021-10-11
RECRUITING
Neurofilament Light Chain And Voice Acoustic Analyses In Dementia DiagnosisNCT06339190 · 2021-08-01
RECRUITING
Neurodegenerative Diseases RegistryNCT04472130 · 2019-10-09
RECRUITING
Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative DiseasesNCT04706234 · 2017-09-01
RECRUITING
Neurologic Stem Cell Treatment StudyNCT02795052 · 2016-06-01
RECRUITING
Observational Pharmaco-Epidemiology Research & AnalysisNCT03813862 · 2013-12-01
RECRUITING
New CSF Biomarkers for Alzheimer's DiseaseNCT03621839 · 2013-07-12
RECRUITING
Beta Amyloid PET/CT in Various Aβ-Related DiseaseNCT06725706 · 2012-09-01
RECRUITING
Clinical Research on Stem Cell Therapy for Parkinson's DiseaseNCT07232147 · 2025-12-01
NOT_YET_RECRUITING
Decision-making, Ethical Consent, and Interactive Dialogue in Ongoing Neurocognitive Decline - DECISIONNCT07514520 · 2025-10-02
ACTIVE_NOT_RECRUITING
Cognitive Impairment Cohort Study of the Elderly Population in YuGardenNCT06325527 · 2024-04-01
NOT_YET_RECRUITING
The Clinical Impact of the Novel Alzheimer's Blood-based BiomarkersNCT06246019 · 2024-02-07
UNKNOWN
Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)NCT06643858 · 2023-12-01
ENROLLING_BY_INVITATION
CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain ImagingNCT06148233 · 2023-09-15
UNKNOWN
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's DiseaseNCT04838301 · 2023-08-15
ACTIVE_NOT_RECRUITING
Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of InflammationNCT05321498 · 2023-06-01
WITHDRAWN
A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's DiseaseNCT05792163 · 2023-03-20
COMPLETED
A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)NCT05738486 · 2023-02-28
ACTIVE_NOT_RECRUITING
An Open-Label Extension of XPro1595 in Patients With Alzheimer's DiseaseNCT05522387 · 2023-02-21
TERMINATED
Cognitive Impairment Cohort Study of the Elderly Population in SheMountainNCT05667935 · 2022-12-26
NOT_YET_RECRUITING
Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy AssessmentNCT06965816 · 2022-11-24
COMPLETED
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)NCT05508789 · 2022-10-10
ACTIVE_NOT_RECRUITING
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative DiseasesNCT05538455 · 2022-09-30
COMPLETED
Role of Saffron and Chamomile in the Management of Parkinson's DiseaseNCT05696665 · 2022-07-05
UNKNOWN
Assessing a Novel Virtual Environment That Assists With Activities of Daily LivingNCT05418296 · 2022-06-09
COMPLETED
HIFT in People With Parkinson's DiseaseNCT05482776 · 2022-04-15
COMPLETED
Immunohistochemical Study of Neurodegenerative DiseasesNCT05518409 · 2022-04-01
UNKNOWN
Exploring the Recovery Function of Sleep in NeurodegenerationNCT05402488 · 2022-03-14
UNKNOWN
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of InflammationNCT05318976 · 2022-02-28
COMPLETED
[18F]MC225-PET in Neurodegenerative DiseaseNCT05853471 · 2022-02-01
UNKNOWN
Harmony at Home: A Pilot Telehealth Program for Rural ADRD CaregiversNCT05202223 · 2022-01-15
COMPLETED
Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register StudyNCT06209515 · 2022-01-01
ACTIVE_NOT_RECRUITING
Understanding Ayurveda Disease Conditions and Treatment ResponsesNCT06167226 · 2021-12-29
COMPLETED
Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's DiseaseNCT04871464 · 2021-11-11
UNKNOWN
Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care SystemsNCT05080777 · 2021-09-28
COMPLETED
Personalized Parkinson Project PSP CohortNCT05501431 · 2021-05-01
COMPLETED
The Efficacy of VESPA 2.0 for Cognitive Rehabilitation in Patients With Mild Cognitive ImpairmentNCT06281314 · 2021-03-01
COMPLETED
A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese PopulationNCT05527288 · 2021-01-28
COMPLETED
Exploratory Evaluation of [11C]MPC6827NCT04575727 · 2021-01-08
COMPLETED
Intensive Multidisciplinary Rehabilitation and Biomarkers in Parkinson's DiseaseNCT05452655 · 2020-12-09
UNKNOWN
The Personalized Parkinson Project De Novo CohortNCT04985539 · 2020-08-29
ACTIVE_NOT_RECRUITING
Pilot Study About Extra Virgin Olive Oil "Coratina" in Mild Cognitive Impairment and Alzheimer's Disease PatientsNCT04229186 · 2020-01-01
UNKNOWN
NAD-supplementation in Drug naïve Parkinson's DiseaseNCT03816020 · 2019-03-09
COMPLETED

Common interventions

Trial status mix

COMPLETED34
RECRUITING25
UNKNOWN12
ACTIVE_NOT_RECRUITING7
NOT_YET_RECRUITING3
TERMINATED2
WITHDRAWN2
ENROLLING_BY_INVITATION1

Phase mix

NA28
PHASE211
PHASE16
PHASE43
EARLY_PHASE12
PHASE32
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.